Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.

نویسندگان

  • A S Rao
  • P Fontes
  • A Iyengar
  • R Shapiro
  • F Dodson
  • R Corry
  • S Pham
  • M Jordan
  • A Zeevi
  • C Rastellini
  • A Aitouche
  • F Egidi
  • H A Gritsch
  • J Reyes
  • J J Fung
  • T E Starzl
چکیده

'"I IE HAVE previo~y documented the long-term perV V sistence of donor cell chimerism after successful organ transplantation (Tx) and have postulated that it plays a seminal role in allograft acceptance and in the induction and perpetration of donor-specific tolerance.1•2 To further enhance the salutary effects of chimerism we have augmented this phenomenon, since December 1992, by infusing unmodified donor bone marrow (BM) into 190 organ allograft recipients; the unavailability of consent to retrieve vertebral bodies has resulted in accrual of 110 contemporaneous controls. We present here an interim analysis of these patients at their most recent follow up.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients.

BACKGROUND We and others have demonstrated that a low level of donor cell chimerism was present for years after transplantation in tissues and peripheral blood of heart and lung recipients; it was associated, in the latter, with a lower incidence of chronic rejection. To augment this phenomenon, we initiated a trial combining simultaneous infusion of donor bone marrow with heart or lung allotra...

متن کامل

Adjuvant bone marrow infusion in clinical organ transplant recipients.

THE two most common causes of late organ allograft failure are complications associated with the longterm use of nonspecific immunosuppression and chronic rejection. Incidentally. this undesirable outcome could be prevented by timely adoption of clinically applicable strategies that would result in the induction of donorspecific tolerance (DST). We have previously advanced the hypothesis that s...

متن کامل

Anti-HLA Antibodies and Kidney Allograft Outcomes in Recipients with Donor Bone Marrow Cell Infusion

Background: Anti-HLA-antibodies are known to affect the allograft survival in transplant recipient patients. Objective: The aim of this study was to evaluate the association between anti-HLA antibodies and kidney allograft outcomes, particularly in recipients with concur-rent donor bone marrow cell infusion (DBMI). Methods: Between June 2006 and May 2007, forty living unrelated donor kidney tra...

متن کامل

Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.

WITH the concept that the persistence of donor leukocyte chimerism plays a seminal role in the acceptance of whole organ allografts,I-4 we initiated a prospective trial in December 1992 to enhance chimerism by adjuvant infusion of unmodified donor bone marrow (BM) in liver, kidney, and thoracic organ recipients.5 Conventional tacrolimus/prednisone immunosuppression was given without any kind of...

متن کامل

Perioperative donor bone marrow infusion in recipients of organ allografts.

D ESPITE its attended complications. immunosuppression for graft acceptance and the impending threat of chronic rejection are two of the many overwhelming factors that have necessitated the implementation of strategies aimed at inducing donor-specific tolerance (OST). With the postulation that persistence of donor cell chimerism after organ transplantation (Tx) may play a notable role in allogr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Transplantation proceedings

دوره 29 1-2  شماره 

صفحات  -

تاریخ انتشار 1997